Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06159361
Other study ID # 20231151
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 6, 2023
Est. completion date December 1, 2024

Study information

Verified date November 2023
Source University of Miami
Contact James Moore, PhD
Phone 5613796461
Email jgmoore@miami.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to examine the effects of a postural adjustment, targeted training program on balance ability and postural responses anticipatory postural adjustments (APA) and compensatory postural adjustments (CPA) in individuals with MS


Recruitment information / eligibility

Status Recruiting
Enrollment 15
Est. completion date December 1, 2024
Est. primary completion date December 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: 1. Must be18 to 70 years of age. 2. Medical diagnosis of MS confirmed by a neurologist. 3. Ability to stand independently without any aid for at least 3 minutes. 4. A Patients determined disease steps (PDDS) score of 5 or lower. 5. Normal or corrected-to-normal vision. 6. English or Spanish speaking. Exclusion Criteria: 1. MS-related exacerbation or medication change in the past two months. 2. Presence of concurrent neurological or orthopedic disorders. 3. Unable to perform the experimental tasks.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Balance targeted exercises
6-week exercise program, 3 sessions per week (2 sessions in person, 1 session of home exercises. Participants will receive a booklet with information about the home exercises and will receive a text message reminder), each session will last 60 minutes.

Locations

Country Name City State
United States University of Miami Miami Florida

Sponsors (1)

Lead Sponsor Collaborator
University of Miami

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in balance ability as measured by the BESTest The Balance Evaluation Systems Test (BESTest) will be used to measure balance ability. Items are scored from 0 (severe impairment) to 3 (no impairment), with a total score of 108. A higher score suggests better balance ability. Baseline, 6 weeks (post intervention)
Primary Change in reaction time Measure in seconds Baseline, 6 weeks (post intervention)
Primary Change in movement velocity Measure in degree per second Baseline, 6 weeks (post intervention)
Primary Change in endpoint excursion percentage measure of endpoint excursion in a percentage out of a100 Baseline, 6 weeks (post intervention)
Primary Change in directional control percentage measure of directional control in a percentage out of a100 Baseline, 6 weeks (post intervention)
Primary Change in maximum excursion percentage measure of maximum excursion in a percentage out of a100 Baseline, 6 weeks (post intervention)
Primary Change in muscle responses latency as measured by MCT The Motor Control test (MCT) measures the subject's ability to generate a motor response latency to a sudden surface translation in a forward and backward direction at three different magnitudes (small, medium, and large).
Latency: The time-lapse between the perturbation onset and the subject response for each limb. The latency is reported in milliseconds.
Baseline, 6 weeks (post intervention)
Primary Change in postural muscles responses latency as measured by Electromyography (EMG) Postural muscles responses onset latency in seconds Baseline, 6 weeks (post intervention)
Primary Change in APA as measured by microvolts Postural muscles APA measured in microvolts Baseline, 6 weeks (post intervention)
Primary Change in CPA as measured by microvolts Postural muscles CPA in microvolts Baseline, 6 weeks (post intervention)
Secondary Change in balance confidence as measured by ABC The Activities Specific Balance Confidence (ABC) scale is a self-report questionnaire of a subject's perceived level of balance confidence. It measures the subject's confidence in performing various ambulatory activities without falling. There are 16 items scored using a scale(0-100) with higher scores indicating more confidence in performing the tasks. A total score is reported by dividing the total ABC score by 16. Baseline, 6 weeks (post intervention)
Secondary Change in quality of life as measured by the MSQoL-54 Multiple Sclerosis Quality of Life - 54 (MSQoL-54) is a self-report questionnaire measuring subject perceived of quality of life. In total, it contains 54 items with a total score ranging from 0-100, with higher scores indicating a better quality of life Baseline, 6 weeks (post intervention)
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4